News
LDC shortlisted as finalist in HealthInvestor Awards 2025
18 Feb 2025
LDC has been named as a finalist in the HealthInvestor Awards 2025, in the Private Equity Investor of the Year category.
The HealthInvestor Awards recognise the achievement of businesses in healthcare and the event is run by leading trade publication HealthInvestor UK. The finalist entries are judged by a panel of high profile, independent judges from across the sector.
LDC has invested over £400m in 18 healthcare businesses the last decade, partnering with some of the most ambitious business leaders in sub sectors including healthcare services, pharma services and Medtech & devices. Using our experience in the sector, our regional teams continue to support a range of growth strategies across our portfolio – whether expanding through organic growth, pursuing buy and build, developing new products, or entering new overseas markets.
Over the last year, LDC has invested in a number of healthcare businesses, including backing the management team of Medray Group to support the healthcare equipment and service provider to expand organically and through acquisition.
The overall winners of all the categories, including Private Equity Investor of the Year, will be announced at the HealthInvestor Awards in London on 4th June 2025.
This recognition for LDC follows the news that Aziz Ul-Haq, Partner at LDC, was named a finalist in HealthInvestor’s Power List for 2024, in the Equity Investor Category.
LDC extends its congratulations to all those who have been named finalists in this year’s HealthInvestor Awards. You can see the full list here.